Sudden death in epilepsy and ectopic neurohypophysis in Joubert syndrome 23 diagnosed using SNVs/indels and structural variants pipelines on WGS data: a case report.


Journal

BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552

Informations de publication

Date de publication:
07 05 2020
Historique:
received: 27 12 2019
accepted: 12 04 2020
entrez: 9 5 2020
pubmed: 10 5 2020
medline: 17 7 2020
Statut: epublish

Résumé

Joubert syndrome (JBTS) is a genetically heterogeneous group of neurodevelopmental syndromes caused by primary cilia dysfunction. Usually the neurological presentation starts with abnormal neonatal breathing followed by muscular hypotonia, psychomotor delay, and cerebellar ataxia. Cerebral MRI shows mid- and hindbrain anomalies including the molar tooth sign. We report a male patient with atypical presentation of Joubert syndrome type 23, thus expanding the phenotype. Clinical features were consistent with JBTS already from infancy, yet the syndrome was not suspected before cerebral MRI later in childhood showed the characteristic molar tooth sign and ectopic neurohypophysis. From age 11 years seizures developed and after few years became increasingly difficult to treat, also related to inadequate compliance to therapy. He died at 23 years of sudden unexpected death in epilepsy (SUDEP). The genetic diagnosis remained elusive for many years, despite extensive genetic testing. We reached the genetic diagnosis by performing whole genome sequencing of the family trio and analyzing the data with the combination of one analysis pipeline for single nucleotide variants (SNVs)/indels and one for structural variants (SVs). This lead to the identification of the most common variant detected in patients with JBTS23 (OMIM# 616490), rs534542684, in compound heterozygosity with a 8.3 kb deletion in KIAA0586, not previously reported. We describe for the first time ectopic neurohypophysis and SUDEP in JBTS23, expanding the phenotype of this condition and raising the attention on the possible severity of the epilepsy in this disease. We also highlight the diagnostic power of WGS, which efficiently detects SNVs/indels and in addition allows the identification of SVs.

Sections du résumé

BACKGROUND
Joubert syndrome (JBTS) is a genetically heterogeneous group of neurodevelopmental syndromes caused by primary cilia dysfunction. Usually the neurological presentation starts with abnormal neonatal breathing followed by muscular hypotonia, psychomotor delay, and cerebellar ataxia. Cerebral MRI shows mid- and hindbrain anomalies including the molar tooth sign. We report a male patient with atypical presentation of Joubert syndrome type 23, thus expanding the phenotype.
CASE PRESENTATION
Clinical features were consistent with JBTS already from infancy, yet the syndrome was not suspected before cerebral MRI later in childhood showed the characteristic molar tooth sign and ectopic neurohypophysis. From age 11 years seizures developed and after few years became increasingly difficult to treat, also related to inadequate compliance to therapy. He died at 23 years of sudden unexpected death in epilepsy (SUDEP). The genetic diagnosis remained elusive for many years, despite extensive genetic testing. We reached the genetic diagnosis by performing whole genome sequencing of the family trio and analyzing the data with the combination of one analysis pipeline for single nucleotide variants (SNVs)/indels and one for structural variants (SVs). This lead to the identification of the most common variant detected in patients with JBTS23 (OMIM# 616490), rs534542684, in compound heterozygosity with a 8.3 kb deletion in KIAA0586, not previously reported.
CONCLUSIONS
We describe for the first time ectopic neurohypophysis and SUDEP in JBTS23, expanding the phenotype of this condition and raising the attention on the possible severity of the epilepsy in this disease. We also highlight the diagnostic power of WGS, which efficiently detects SNVs/indels and in addition allows the identification of SVs.

Identifiants

pubmed: 32381069
doi: 10.1186/s12881-020-01024-y
pii: 10.1186/s12881-020-01024-y
pmc: PMC7204034
doi:

Substances chimiques

Cell Cycle Proteins 0
KIAA0586 protein, human 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

96

Références

J Med Genet. 2015 Dec;52(12):830-9
pubmed: 26386044
J Med Genet. 2019 Apr;56(4):261-264
pubmed: 30120217
BMC Biol. 2013 Mar 28;11:27
pubmed: 23537390
Am J Med Genet A. 2017 May;173(5):1237-1242
pubmed: 28371402
Sci Rep. 2018 Feb 2;8(1):2211
pubmed: 29396404
J Pathol. 2017 Jan;241(2):294-309
pubmed: 27859258
Bioinformatics. 2016 Apr 15;32(8):1220-2
pubmed: 26647377
Genet Med. 2017 Aug;19(8):875-882
pubmed: 28125082
Elife. 2015 Sep 19;4:
pubmed: 26386247
Am J Hum Genet. 2015 Aug 6;97(2):311-8
pubmed: 26166481
Am J Med Genet C Semin Med Genet. 2009 Nov 15;151C(4):326-40
pubmed: 19876931
Curr Opin Genet Dev. 2019 Jun;56:41-48
pubmed: 31326647
Elife. 2015 May 30;4:e06602
pubmed: 26026149
Am J Med Genet A. 2020 Jan;182(1):229-249
pubmed: 31710777
J Cell Biol. 2014 Jan 20;204(2):215-29
pubmed: 24421332
Seizure. 2017 Jan;44:232-236
pubmed: 27773556
Hum Mutat. 2015 Sep;36(9):831-5
pubmed: 26096313
Neurology. 2020 Jan 28;94(4):e419-e429
pubmed: 31831600

Auteurs

Dulika Sumathipala (D)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Petter Strømme (P)

Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Faculty of Medicine, University of Oslo, Oslo, Norway.

Christian Gilissen (C)

Department of Human Genetics, Radboud UMC, Nijmegen, The Netherlands.

Ingunn Holm Einarsen (IH)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Hilde J Bjørndalen (HJ)

Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Andrés Server (A)

Section of Neuroradiology, Department of Radiology and Nuclear Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Jordi Corominas (J)

Department of Human Genetics, Radboud UMC, Nijmegen, The Netherlands.

Bjørnar Hassel (B)

Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Neurohabilitation and Complex Neurology, Oslo University Hospital, Ullevål, Oslo, Norway.

Madeleine Fannemel (M)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Doriana Misceo (D)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway. doriana.misceo@medisin.uio.no.

Eirik Frengen (E)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH